Abstract
It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Current Signal Transduction Therapy
Title:How India Fights with COVID-19 Learning from Highly Affected Countries
Volume: 16 Issue: 3
Author(s): Pooja Sharma and Karan Veer*
Affiliation:
- Department of Instrumentation & Control Engineering, Dr. B.R. Ambedkar National Institute of Technology, Jalandhar 144011,India
Keywords: Death rate, different scenario, fight against COVID-19, remedial action, WHO, risk assessment.
Abstract: It was 11 March 2020 when the World Health Organization (WHO) declared the name COVID-19 for coronavirus disease and also described it as a pandemic. Till that day 118,000 cases were confirmed of pneumonia with breathing problem throughout the world. At the start of New Year when COVID-19 came into knowledge a few days later, the gene sequencing of the virus was revealed. Today the number of confirmed cases is scary, i.e. 9,472,473 in the whole world and 484,236 deaths have been recorded by WHO till 26 June 2020. WHO's global risk assessment is very high [1]. The report is enlightening the lessons learned by India from the highly affected countries.
Export Options
About this article
Cite this article as:
Sharma Pooja and Veer Karan *, How India Fights with COVID-19 Learning from Highly Affected Countries, Current Signal Transduction Therapy 2021; 16 (3) . https://dx.doi.org/10.2174/1574362415999200807154418
DOI https://dx.doi.org/10.2174/1574362415999200807154418 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Preliminary Identification of Hamamelitannin and Rosmarinic Acid as COVID-19 Inhibitors Based on Molecular Docking
Letters in Drug Design & Discovery Hispidin and Lepidine E: Two Natural Compounds and Folic Acid as Potential Inhibitors of 2019-novel Coronavirus Main Protease (2019- nCoVM<sup>pro</sup>), Molecular Docking and SAR Study
Current Computer-Aided Drug Design Bioproducts from Seaweeds: A Review with Special Focus on the Iberian Peninsula
Current Organic Chemistry SARS-CoV-2 Spread Dynamics in Italy: The Calabria Experience
Reviews on Recent Clinical Trials The Role of CO-RADS Scoring System in the Diagnosis of COVID-19 Infection and its Correlation with Clinical Signs
Current Medical Imaging Natural Compounds as Heme Oxygenase-1 Inducers to Reduce the Deleterious Consequences Following SARS-CoV-2 Infection
Current Chemical Biology Mechanistic Insights to the Binding of Antibody CR3022 Against RBD from SARS-CoV and HCoV-19/SARS-CoV-2: A Computational Study
Combinatorial Chemistry & High Throughput Screening Coronavirus Disease 2019 (COVID-19): Current Situation and Therapeutic Options
Coronaviruses Modulation of γ<sub>2</sub>-MSH Hepatoprotection by Antisense Peptides and Melanocortin Subtype 3 and 4 Receptor Antagonists
Medicinal Chemistry The Compound 6-Chloro-1,4-Dihydro-4-Oxo-1-(β-D-Ribofuranosyl) Quinoline-3-Carboxylic Acid Inhibits HIV-1 Replication by Targeting the Enzyme Reverse Transcriptase
Current HIV Research COVID-19: An Opinion of Prevention and Dietary Based Management Hypothesis
Coronaviruses A Note on the Potential BCG Vaccination – COVID-19 Molecular Link
Coronaviruses <i>Chemi-Informatic</i> Approach to Investigate Putative Pharmacoactive Agents of Plant Origin to Eradicate COVID-19
Coronaviruses Analyses of Protein Sequences Using Inter-Residue Average Distance Statistics to Study Folding Processes and the Significance of Their Partial Sequences
Protein & Peptide Letters New Approaches for the Treatment of Chagas Disease
Current Drug Targets Viral Diseases and Natural Products: Prospects in COVID-19 Treatment (Part II)
Current Pharmaceutical Design Azithromycin Use in COVID-19 Patients: Implications on the Antimicrobial Resistance
Current Topics in Medicinal Chemistry Cardiovascular Manifestations of COVID-19
Current Cardiology Reviews Epidemiological Features of the 2019 Novel Coronavirus Outbreak in China
Current Topics in Medicinal Chemistry <i>In Silico</i> Identification of Potential Inhibitors of SARS-CoV-2 Papain-like Protease From Natural Sources: A Natural Weapon to Fight COVID-19
Coronaviruses